The FDA has issued a proposal to remove a common decongestant in over the counter products.
Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback